Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez
This study consists of a open label randomized controlled clinical trial comprised of 20 patients with diagnosis of functional neurological symptom disorder with non epileptic seizures distributed in 2 arms of 10 patients each.
Patients will be randomly assigned to one of the groups. Both groups will be receiving treatment as usual (SSRI and/or psychotherapy). One group will be assigned a ketogenic diet while the other will be assigned a healthy diet, both supervised by a team of nutritionists. Patients will be evaluated every 2 weeks until reaching 6 weeks.
Age
17–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients who have a record at the institute and who have a diagnosis of a dissociative neurological symptom disorder with non-epileptic seizures with a certainty of at least clinically established who have a monthly seizure frequency greater than 3.
Patients with the characteristics described above with comorbid epilepsy but who have not presented epileptic seizures in the last month.
Patients with the aforementioned characteristics and who give their informed consent in writing to participate in the study.
Patients who, once the diet has been explained to them, consider it feasible to implement it at least for the follow-up time.
You may not be if
Patients with metabolic or hemodynamic instability, liver failure, inability to tolerate the oral route, acute pancreatitis or pregnancy due to the possible teratogenic effect that has not yet been elucidated.
Patients with metabolic disorders such as primary carnitine deficiency, palmitoyltransferase carnitine I or II deficiency, carnitine translocase deficiency, beta oxidation defects, pyruvate carboxylase deficiency, porphyria and other fatty acid transport and oxidation disorders.
